Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [481]

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma expressing PD-L1

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2...

Breast cancer study altered guidelines in Sweden

Breast cancer study altered guidelines in Sweden

New resource to help families understand paediatric Hodgkin lymphoma

New resource to help families understand paediatric Hodgkin lymphoma

Cuproptosis-related MTF1 inhibits kidney renal clear cell carcinoma progression by suppressing proliferation and regulating immune cell infiltration

Cuproptosis-related MTF1 inhibits kidney renal clear cell carcinoma progression by suppressing proliferation and...

MRI scans improve prostate cancer diagnosis in screening trial

MRI scans improve prostate cancer diagnosis in screening trial

Natural-product inspired small molecule drug targets ‘undruggable’ target

Natural-product inspired small molecule drug targets ‘undruggable’ target

Policies favouring high-volume hospitals may disadvantage rural cancer patients

Policies favouring high-volume hospitals may disadvantage rural cancer patients

New breast cancer susceptibility genes

New breast cancer susceptibility genes

Adherence to a Mediterranean lifestyle associated with lower risk of all-cause and cancer mortality

Adherence to a Mediterranean lifestyle associated with lower risk of all-cause and cancer mortality

FDA approves melphalan as a liver-directed treatment for uveal melanoma

FDA approves melphalan as a liver-directed treatment for uveal melanoma

More from ecancer